VIVUS Inc (VVUS.O)

VVUS.O on Nasdaq

2.31USD
1 May 2015
Change (% chg)

$0.08 (+3.59%)
Prev Close
$2.23
Open
$2.27
Day's High
$2.32
Day's Low
$2.24
Volume
1,506,377
Avg. Vol
2,142,755
52-wk High
$5.95
52-wk Low
$2.22

VVUS.O

Chart for VVUS.O

About

Vivus, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. The Company's drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of... (more)

Overall

Beta: 1.13
Market Cap(Mil.): $242.05
Shares Outstanding(Mil.): 103.88
Dividend: --
Yield (%): --

Financials

  VVUS.O Industry Sector
P/E (TTM): -- 39.17 40.23
EPS (TTM): -0.80 -- --
ROI: -23.98 15.86 15.26
ROE: -70.07 16.36 16.08
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks